Results 311 to 320 of about 79,054 (352)
Some of the next articles are maybe not open access.
Current Treatment Options in Neurology, 2011
Tardive dyskinesia (TD) is iatrogenic (drug-induced); hence the best strategy is prevention. Try to limit exposure to any dopamine receptor blocking agents (DRBAs) if possible. These agents may be unavoidable in some psychiatric conditions such as schizophrenia, but alternative therapies can be used in many situations, such as in the treatment of ...
Pratibha G, Aia +3 more
openaire +2 more sources
Tardive dyskinesia (TD) is iatrogenic (drug-induced); hence the best strategy is prevention. Try to limit exposure to any dopamine receptor blocking agents (DRBAs) if possible. These agents may be unavoidable in some psychiatric conditions such as schizophrenia, but alternative therapies can be used in many situations, such as in the treatment of ...
Pratibha G, Aia +3 more
openaire +2 more sources
Australasian Radiology, 1963
SUMMARYVarious types of abnormal movements of the oesophagus have been discussed. It has been shown that there is a gentle gradation between tertiary wave formation, idiopathic diffuse spasm and achalasia, such that it becomes difficult at times to put each case into its proper compartment.
openaire +2 more sources
SUMMARYVarious types of abnormal movements of the oesophagus have been discussed. It has been shown that there is a gentle gradation between tertiary wave formation, idiopathic diffuse spasm and achalasia, such that it becomes difficult at times to put each case into its proper compartment.
openaire +2 more sources
Movement Disorders, 2007
AbstractLevodopa‐induced dyskinesias (LID) are common and difficult to treat. This review focuses on three issues related to LID: clinical features, classification and rating, pathophysiology and pathogenesis, and management. The three primary clinical syndromes are OFF‐period dystonia, peak‐dose dyskinesia, and diphasic dyskinesia. Several other forms
FABBRINI, Giovanni +4 more
openaire +3 more sources
AbstractLevodopa‐induced dyskinesias (LID) are common and difficult to treat. This review focuses on three issues related to LID: clinical features, classification and rating, pathophysiology and pathogenesis, and management. The three primary clinical syndromes are OFF‐period dystonia, peak‐dose dyskinesia, and diphasic dyskinesia. Several other forms
FABBRINI, Giovanni +4 more
openaire +3 more sources
Australian & New Zealand Journal of Psychiatry, 1994
A case of fluoxetine induced dyskinesia in an elderly woman with previous use of low dose haloperidol is described. In contrast to neuroleptic induced tardive dyskinesia it was characterised by a rapid onset after commencing fluoxetine and rapid resolution on cessation.
A, Mander +4 more
openaire +2 more sources
A case of fluoxetine induced dyskinesia in an elderly woman with previous use of low dose haloperidol is described. In contrast to neuroleptic induced tardive dyskinesia it was characterised by a rapid onset after commencing fluoxetine and rapid resolution on cessation.
A, Mander +4 more
openaire +2 more sources
British Journal of Psychiatry, 1972
The first three cases of tardive dyskinesia were described in a brief communication by Schonecker (1957), and in the following ten years some 600 new cases were reported in 37 papers. Since the literature up to 1967 has been reviewed by Ayd (1967a) and myself (1968a), this communication will deal mainly with the publications of the last five years.
openaire +2 more sources
The first three cases of tardive dyskinesia were described in a brief communication by Schonecker (1957), and in the following ten years some 600 new cases were reported in 37 papers. Since the literature up to 1967 has been reviewed by Ayd (1967a) and myself (1968a), this communication will deal mainly with the publications of the last five years.
openaire +2 more sources
Journal of Speech and Hearing Disorders, 1970
S, Maxwell, R, Massengill, B, Nashold
openaire +2 more sources
S, Maxwell, R, Massengill, B, Nashold
openaire +2 more sources
Levodopa-induced dyskinesia: clinical features, incidence, and risk factors
Journal of neural transmission, 2018T. Tran +3 more
semanticscholar +1 more source
[Senile dyskinesias and tardive dyskinesias].
L'Encephale, 1989Correct recognition of spontaneous linguobucco-facial dyskinesia is at least of interest in that it enables accurate evaluation of the impact of neuroleptic medication on the occurrence of similar neurological disorders. Since 1963, first anecdotal evidence and then series of cases of spontaneous dyskinesia have been reported.
S, Brion +3 more
openaire +1 more source
Animal models of l‐dopa‐induced dyskinesia in Parkinson's disease
Movement Disorders, 2018M. Cenci, A. Crossman
semanticscholar +1 more source